Clinica chimica acta; international journal of clinical chemistry (2015 Jan)
p. 84-90 issn:1873-3492)
High levels of circulating forms of the urokinase-type plasminogen activator receptor (uPAR) are significantly associated to poor prognosis in cancer patients. Our aim was to determine biological variations and reference intervals of the uPAR forms in blood, and in addition, to test the clinical relevance of using these as cut-points in colorectal cancer (CRC) prognosis.
Forfattere: Thurison T, Christensen IJ, Lund IK, Nielsen HJ, Høyer-Hansen G